FDA uncovers falsified research data from contractor Cetero

07/26/2011 | Reuters

Drugmakers might need to re-evaluate bioanalytical data provided by Cetero Research to support new-drug applications between April 2005 and June 2010, the FDA said. The agency said it uncovered falsified clinical data during May and December inspections of the contract research organization's Houston facility.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ